6:04 PM
 | 
Dec 14, 2012
 |  BC Extra  |  Top Story

Ariad falls on ponatinib boxed warning

Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) fell $4.95 (21%) to $18.93 on Friday after FDA said it included a boxed warning on the label for the company's newly approved leukemia drug Iclusig ponatinib. FDA granted accelerated approval to Iclusig to treat chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) that...

Read the full 250 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >